Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.085 USD | +0.46% | +5.94% | +94.55% |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
04-01 | Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.